Clinical Trial Update: Impact of Combined of Lantus(Insulin Glargine) and Lyxumia (Lixisenatide) on Insulin Secretion and Gastric Emptying [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the combined use of Lantus (insulin glargine) and Lyxumia (lixisenatide) to evaluate effects on insulin secretion and gastric emptying i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Lantus (insulin glargine)
• Lyxumia (lixisenatide)

Snippet

Sponsor: Profil Institut für Stoffwechselforschung GmbH | Conditions: Diabetes Mellitus | Phase 2 | Status: COMPLETED